Progesterone level at oocyte retrieval predicts in vitro fertilization success in a short-antagonist protocol: A prospective cohort study

Fertility and Sterility

Volumn 101, Issue 3, 2014, Pages

  Nayak, Shweta ^a,b   Ochalski, Melanie E ^a,b,c   Fu, Bo ^d   Wakim, Kathryn Mary ^a   Chu, Tian Jao ^b   Dong, Xinxin ^d   Wakim, Anthony N ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Fertility Center   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

antagonist cycle; oocyte retrieval; Progesterone level

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GANIRELIX; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DRUG BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; IMPLANTATION; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY HYPERSTIMULATION; PATIENT MONITORING; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ANTAGONIST CYCLE; OOCYTE RETRIEVAL; PROGESTERONE LEVEL;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; HUMANS; OOCYTE RETRIEVAL; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; PROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84894475649     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.11.022     Document Type: Article

References (41)

1. E. Bosch, E. Labarta, J. Crespo, C. Simon, J. Remohi, and J. Jenkins et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles Hum Reprod 25 2010 2092 2100
2. C.A. Venetis, E.M. Kolibianakis, E. Papanikolaou, J. Bontis, P. Devroey, and B.C. Tarlatzis Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis Humanit Rep Update 13 2007 343 355
3. C.A. Venetis, E.M. Kolibianakis, and B.C. Tarlatzis Progesterone elevation and probability of pregnancy after IVF: facts and fiction Hum Reprod Update 14 2008 538
4. J.S. Younis "Premature luteinization" in the era of GnRH analogue protocols: time to reconsider J Assist Reprod Genet 28 2011 689 692
5. A.M. Elnashar Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update J Assist Reprod Genet 27 2010 149 155
6. G.E. Hofmann, F. Bentzien, P.A. Bergh, G.J. Garrisi, M.C. Williams, and I. Guzman et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality Fertil Steril 60 1993 675 679
7. J.S. Younis, A. Simon, and N. Laufer Endometrial preparation: lessons from oocyte donation Fertil Steril 66 1996 873 884
8. A.B. Copperman, G.M. Horowitz, P. Kaplan, R.T. Scott, D. Navot, and G.E. Hofmann Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation Fertil Steril 63 1995 1267 1271
9. F. Ubaldi, C. Albano, M. Peukert, H. Riethmuller-Winzen, M. Camus, and J. Smitz et al. Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles Hum Reprod 11 1996 1405 1407
10. J.S. Younis, M. Matilsky, O. Radin, and M. Ben-Ami Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist Fertil Steril 76 2001 294 299
11. S.A. Pangas, X. Li, E.J. Robertson, and M.M. Matzuk Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice Mol Endocrinol 20 2006 1406 1422
12. R.S. Legro, B.A. Ary, R.J. Paulson, F.Z. Stanczyk, and M.V. Sauer Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization Hum Reprod 8 1993 1506 1511
13. R. Lahoud, M. Kwik, J. Ryan, M. Al-Jefout, J. Foley, and P. Illingworth Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality Arch Gynecol Obstet 285 2012 535 540
14. R. Fanchin, C. Righini, F. Olivennes, A.L. Ferreira, D. de Ziegler, and R. Frydman Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy Fertil Steril 68 1997 799 805
15. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group Hum Reprod 13 1998 3023 3031
16. S. Dovey, K. McIntyre, D. Jacobson, J. Catov, and A. Wakim Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in vitro fertilization cycles Fertil Steril 96 2011 585 589
17. K.M. Silverberg, W.N. Burns, D.L. Olive, R.M. Riehl, and R.S. Schenken Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins J Clin Endocrinol Metab 73 1991 797 803
18. M.C. Edelstein, H.J. Seltman, B.J. Cox, S.M. Robinson, R.A. Shaw, and S.J. Muasher Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome Fertil Steril 54 1990 853 857
19. E. Bosch, I. Valencia, E. Escudero, J. Crespo, C. Simon, and J. Remohi et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Fertil Steril 80 2003 1444 1449
20. R. Ochsenkuhn, A. Arzberger, V. von Schonfeldt, J. Gallwas, N. Rogenhofer, and A. Crispin et al. Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers Fertil Steril 98 2012 347 354
21. Z. Niu, Y. Feng, A. Zhang, Y. Sun, and H. Zhang Progesterone levels on oocyte retrieval day can predict the quantity of viable embryos but not pregnancy outcome of intracytoplasmic sperm injection Gynecol Endocrinol 24 2008 452 458
22. M.I. Abuzeid, and M.A. Sasy Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer Fertil Steril 65 1996 981 985
23. K.F. Miller, E.J. Behnke, R.L. Arciaga, J.M. Goldberg, N.W. Chin, and S.G. Awadalla The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support J Assist Reprod Genet 13 1996 698 701
24. D.V. Moffitt, J.T. Queenan Jr., R. Shaw, and S.J. Muasher Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort Fertil Steril 67 1997 296 301
25. N. Doldi, E. Marsiglio, A. Destefani, A. Gessi, G. Merati, and A. Ferrari Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome Hum Reprod 14 1999 601 605
26. B. Urman, C. Alatas, S. Aksoy, R. Mercan, A. Isiklar, and B. Balaban Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer Fertil Steril 72 1999 975 979
27. F. Martinez, B. Coroleu, E. Clua, R. Tur, R. Buxaderas, and N. Parera et al. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles Reprod Biomed Online 8 2004 183 190
28. J.H. Check, C. Hourani, J.K. Choe, C. Callan, and H.G. Adelson Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program Fertil Steril 61 1994 262 264
29. J.H. Check, D. Lurie, H.A. Askari, L. Hoover, and C. Lauer The range of subtle rise in serum progesterone levels following controlled ovarian hyperstimulation associated with lower in vitro fertilization pregnancy rates is determined by the source of manufacturer Eur J Obstet Gynecol Reprod Biol 52 1993 205 209
30. R. Fanchin, D. de Ziegler, J. Taieb, A. Hazout, and R. Frydman Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer Fertil Steril 59 1993 1090 1094
31. R. Fanchin, A. Hourvitz, F. Olivennes, J. Taieb, A. Hazout, and R. Frydman Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture Fertil Steril 68 1997 648 652
32. T. Harada, S. Yoshida, C. Katagiri, N. Takao, T. Ikenari, and T. Toda et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin Hum Reprod 10 1995 1060 1064
33. A. Shulman, Y. Ghetler, Y. Beyth, and I. Ben-Nun The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins J Assist Reprod Genet 13 1996 207 211
34. E.G. Papanikolaou, E.M. Kolibianakis, C. Pozzobon, P. Tank, H. Tournaye, and C. Bourgain et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer Fertil Steril 91 2009 949 952
35. K.M. Seow, Y.H. Lin, L.W. Huang, B.C. Hsieh, S.C. Huang, and C.Y. Chen et al. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles Gynecol Endocrinol 23 2007 338 342
36. S. Segal, I. Glatstein, P. McShane, S. Hotamisligil, D. Ezcurra, and R. Carson Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome Fertil Steril 91 2009 1755 1759
37. A.J. Polotsky, J.L. Daif, S. Jindal, H.J. Lieman, N. Santoro, and L. Pal Serum progesterone on the day of human chorionic gonadotropin administration predicts clinical pregnancy of sibling frozen embryos Fertil Steril 92 2009 1880 1885
38. L Corti, E Papaleo, L Pagliardini, E Rabellotti, M Molgora, and A LaMarca et al. Fresh Blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggerin: a strategy in the context of Italian law Eur J Obstet Gynecol Reprod Biol 171 2012 73 77
39. R. Fanchin, C. Righini, F. Olivennes, J. Taieb, D. de Ziegler, and R. Frydman Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation Fertil Steril 71 1999 174 181
40. M.A. Melo, M. Meseguer, N. Garrido, E. Bosch, A. Pellicer, and J. Remohi The significance of premature luteinization in an oocyte-donation programme Hum Reprod 21 2006 1503 1507
41. E.M. Kolibianakis, K. Zikopoulos, J. Smitz, M. Camus, H. Tournaye, and A.C. Van Steirteghem et al. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists Hum Reprod 19 2004 1525 1529